|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.40 GBX | -1.45% |
|
-1.78% | -10.22% |
| 06-24 | Berenberg Says Investors 'Underappreciating' Mitie Group Investment Case; Price Target Up | MT |
| 06-24 | Berenberg says buy NatWest, hold Lloyds | AN |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.42 | 4.53 | 5.94 | 6.04 | 6 | |||||
Return on Total Capital | 8.65 | 11.53 | 14.84 | 15.29 | 14.82 | |||||
Return On Equity % | 7.99 | 21.5 | 29.24 | 24.04 | 18.8 | |||||
Return on Common Equity | 7.99 | 21.5 | 28.87 | 23.48 | 17.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 11.57 | 11.06 | 11.25 | 11.21 | 11.68 | |||||
SG&A Margin | 8.46 | 6.97 | 6.53 | 7.48 | 7.72 | |||||
EBITDA Margin % | 3.15 | 4.12 | 4.81 | 4.67 | 5.04 | |||||
EBITA Margin % | 2.92 | 3.9 | 4.57 | 4.43 | 4.73 | |||||
EBIT Margin % | 2.42 | 3.35 | 4.01 | 3.85 | 3.99 | |||||
Income From Continuing Operations Margin % | 0.8 | 2.31 | 2.94 | 2.13 | 1.61 | |||||
Net Income Margin % | 1.3 | 2.31 | 2.84 | 2 | 1.47 | |||||
Net Avail. For Common Margin % | 0.8 | 2.31 | 2.84 | 2 | 1.47 | |||||
Normalized Net Income Margin | 1.27 | 2.05 | 2.36 | 2.06 | 2.03 | |||||
Levered Free Cash Flow Margin | 5.59 | 2.87 | 4.57 | 3.02 | 4.15 | |||||
Unlevered Free Cash Flow Margin | 5.82 | 3.06 | 4.74 | 3.24 | 4.47 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.26 | 2.16 | 2.37 | 2.51 | 2.41 | |||||
Fixed Assets Turnover | 29.82 | 26.23 | 24.59 | 22.51 | 22.05 | |||||
Receivables Turnover (Average Receivables) | 10.43 | 9.43 | 10.31 | 10.7 | 10 | |||||
Inventory Turnover (Average Inventory) | 280.61 | 276.26 | 279.81 | 304.93 | 238.57 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.94 | 0.98 | 0.93 | 0.94 | 0.89 | |||||
Quick Ratio | 0.9 | 0.93 | 0.87 | 0.88 | 0.81 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.08 | 0.18 | 0.18 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 35.01 | 38.73 | 35.5 | 34.1 | 36.51 | |||||
Days Outstanding Inventory (Average Inventory) | 1.3 | 1.32 | 1.31 | 1.2 | 1.53 | |||||
Average Days Payable Outstanding | 14.08 | 18.99 | 18.65 | 15.23 | 17.87 | |||||
Cash Conversion Cycle (Average Days) | 22.23 | 21.05 | 18.16 | 20.07 | 20.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 70.6 | 67.82 | 67.87 | 87.64 | 103.92 | |||||
Total Debt / Total Capital | 41.38 | 40.41 | 40.43 | 46.71 | 50.96 | |||||
LT Debt/Equity | 30.41 | 60.23 | 52.29 | 75.44 | 92.19 | |||||
Long-Term Debt / Total Capital | 17.83 | 35.89 | 31.15 | 40.21 | 45.21 | |||||
Total Liabilities / Total Assets | 76.62 | 76.92 | 75.43 | 79.81 | 79.07 | |||||
EBIT / Interest Expense | 6.55 | 10.76 | 14.62 | 10.68 | 7.72 | |||||
EBITDA / Interest Expense | 10.78 | 16 | 20.61 | 16.01 | 12.11 | |||||
(EBITDA - Capex) / Interest Expense | 9.71 | 15.11 | 19.66 | 14.7 | 10.96 | |||||
Total Debt / EBITDA | 1.94 | 1.45 | 1.28 | 1.28 | 1.58 | |||||
Net Debt / EBITDA | -0.41 | 0.19 | 0.3 | 0.66 | 1.27 | |||||
Total Debt / (EBITDA - Capex) | 2.15 | 1.54 | 1.34 | 1.39 | 1.74 | |||||
Net Debt / (EBITDA - Capex) | -0.46 | 0.2 | 0.32 | 0.72 | 1.4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 56.19 | 1.07 | 12.68 | 14.34 | 10.55 | |||||
Gross Profit, 1 Yr. Growth % | 63.52 | -3.39 | 14.52 | 13.96 | 15.2 | |||||
EBITDA, 1 Yr. Growth % | 82.07 | 31.93 | 31.59 | 10.61 | 14.74 | |||||
EBITA, 1 Yr. Growth % | 90.62 | 35.06 | 32.21 | 10.18 | 13.22 | |||||
EBIT, 1 Yr. Growth % | 81.35 | 40.3 | 34.84 | 8.91 | 9.32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -321.99 | 191.05 | 43.69 | -17.19 | -16.7 | |||||
Net Income, 1 Yr. Growth % | -834.78 | 79.68 | 38.64 | -19.72 | -18.54 | |||||
Normalized Net Income, 1 Yr. Growth % | 121.73 | 62.31 | 29.67 | -0.56 | 3.09 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -253.55 | 210 | 46.77 | -16.48 | -19.74 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.59 | 16.7 | -8.72 | 30.81 | 8.82 | |||||
Inventory, 1 Yr. Growth % | -6.3 | 13.45 | 8.89 | 1.36 | 79.19 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 22.05 | 9.03 | 30.47 | 20.62 | 6.4 | |||||
Total Assets, 1 Yr. Growth % | 11.82 | 0.33 | 5.49 | 9.95 | 20.03 | |||||
Tangible Book Value, 1 Yr. Growth % | -32.22 | 6.55 | 34.01 | 32.41 | 98.62 | |||||
Common Equity, 1 Yr. Growth % | 19.1 | -0.96 | 7.47 | -9.44 | 25.32 | |||||
Cash From Operations, 1 Yr. Growth % | 946.36 | -63.94 | 138.19 | 11.28 | 12.09 | |||||
Capital Expenditures, 1 Yr. Growth % | 102.63 | -29.22 | 5.5 | 108.7 | 39.17 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 425.55 | -48.03 | 79.64 | -24.83 | 46.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 351.37 | -46.7 | 74.52 | -22.13 | 47.34 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 61.11 | 37.93 | 7.5 | 4.65 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 34 | 25.64 | 6.72 | 13.51 | 12.43 | |||||
Gross Profit, 2 Yr. CAGR % | 25.36 | 25.69 | 5.19 | 14.24 | 14.58 | |||||
EBITDA, 2 Yr. CAGR % | 14.65 | 55.11 | 31.76 | 20.96 | 14.86 | |||||
EBITA, 2 Yr. CAGR % | 15.91 | 60.45 | 33.63 | 21.02 | 14 | |||||
EBIT, 2 Yr. CAGR % | 6.98 | 59.51 | 37.54 | 21.56 | 11.71 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -12.09 | 154.18 | 104.5 | 9.08 | -16.94 | |||||
Net Income, 2 Yr. CAGR % | -25.15 | 263.36 | 57.83 | 5.5 | -19.13 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.51 | 89.71 | 45.08 | 13.93 | 4.05 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -57.22 | 118.18 | 113.31 | 10.72 | -18.13 | |||||
Accounts Receivable, 2 Yr. CAGR % | 32.75 | 11.53 | 3.21 | 9.27 | 19.31 | |||||
Inventory, 2 Yr. CAGR % | 57.45 | 3.1 | 11.14 | 5.06 | 34.77 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.96 | 15.36 | 19.27 | 25.44 | 13.28 | |||||
Total Assets, 2 Yr. CAGR % | 30.52 | 5.92 | 2.88 | 7.7 | 14.88 | |||||
Tangible Book Value, 2 Yr. CAGR % | -26.53 | -15.02 | 19.49 | 33.21 | 62.17 | |||||
Common Equity, 2 Yr. CAGR % | 129.99 | 8.61 | 3.17 | -1.35 | 6.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 80.96 | 94.24 | -7.33 | 62.81 | 11.68 | |||||
Capital Expenditures, 2 Yr. CAGR % | 37.04 | 19.76 | -13.59 | 48.39 | 70.42 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 122.7 | 65.11 | -3.38 | 16.4 | 6.95 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 107.17 | 54.96 | -3.56 | 16.77 | 9.01 | |||||
Dividend Per Share, 2 Yr. CAGR % | 16.34 | - | 49.07 | 21.77 | 6.07 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 23.24 | 21.98 | 21.16 | 9.2 | 12.51 | |||||
Gross Profit, 3 Yr. CAGR % | 17.08 | 14.93 | 21.85 | 8.04 | 14.56 | |||||
EBITDA, 3 Yr. CAGR % | 8.21 | 20.21 | 46.84 | 24.51 | 20.39 | |||||
EBITA, 3 Yr. CAGR % | 9.49 | 21.97 | 50.42 | 25.53 | 19.99 | |||||
EBIT, 3 Yr. CAGR % | 6.58 | 17.1 | 50.82 | 27.51 | 19.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.47 | 31.03 | 110.17 | 51.3 | -0.29 | |||||
Net Income, 3 Yr. CAGR % | 17.95 | 0.22 | 163.54 | 25.99 | -3.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | 6.71 | 24.1 | 67.11 | 28.2 | 12.22 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -31.42 | -17.22 | 91.17 | 56.05 | -0.54 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.25 | 27.17 | 4.33 | 11.69 | 9.12 | |||||
Inventory, 3 Yr. CAGR % | 28.56 | 41.16 | 5 | 7.78 | 25.52 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 70.56 | 12.3 | 20.19 | 19.72 | 18.74 | |||||
Total Assets, 3 Yr. CAGR % | 22.79 | 19.56 | 5.78 | 5.19 | 11.66 | |||||
Tangible Book Value, 3 Yr. CAGR % | -27.79 | -16.84 | -1.09 | 23.65 | 52.18 | |||||
Common Equity, 3 Yr. CAGR % | 225.03 | 73.67 | 8.23 | -1.22 | 6.84 | |||||
Cash From Operations, 3 Yr. CAGR % | 79.5 | 5.69 | 107.9 | -1.5 | 43.76 | |||||
Capital Expenditures, 3 Yr. CAGR % | 8.37 | 9.95 | 14.81 | 15.94 | 45.25 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 45.02 | 37.02 | 69.82 | -11.03 | 27.27 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 42.18 | 31.68 | 61.23 | -10.1 | 27.66 | |||||
Dividend Per Share, 3 Yr. CAGR % | -23.37 | 29.67 | - | 33.68 | 15.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.95 | 14.2 | 16.34 | 18.52 | 17.59 | |||||
Gross Profit, 5 Yr. CAGR % | 14.48 | 10.26 | 12.17 | 14.66 | 18.89 | |||||
EBITDA, 5 Yr. CAGR % | 34.62 | 8.8 | 17.11 | 20.51 | 33.24 | |||||
EBITA, 5 Yr. CAGR % | 51.62 | 10.29 | 18.57 | 21.59 | 34.78 | |||||
EBIT, 5 Yr. CAGR % | 62.98 | 10.31 | 18.02 | 18.86 | 33.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -9.23 | 40.74 | 42.09 | 21.76 | 44.98 | |||||
Net Income, 5 Yr. CAGR % | -22.73 | 27.44 | 32.52 | 2.3 | 64.3 | |||||
Normalized Net Income, 5 Yr. CAGR % | 28.32 | 14.82 | 20.66 | 19.93 | 38.44 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -32.9 | 4.74 | 7.98 | -7.01 | 36.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.73 | 6.03 | 11.99 | 19.68 | 10.08 | |||||
Inventory, 5 Yr. CAGR % | 11.84 | 14.37 | 21.29 | 25.43 | 16.02 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 34.83 | 36.1 | 47.82 | 17.38 | 17.38 | |||||
Total Assets, 5 Yr. CAGR % | 10.98 | 15.57 | 14.4 | 14.67 | 9.33 | |||||
Tangible Book Value, 5 Yr. CAGR % | -15.37 | -17.38 | -11.67 | 0.41 | 20.54 | |||||
Common Equity, 5 Yr. CAGR % | 37.23 | 77.4 | 105.39 | 38.51 | 7.54 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.39 | 53.31 | 37.79 | 25.63 | 62.15 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.21 | -7.16 | -1.01 | 23.96 | 34.46 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.46 | 25.4 | 23.23 | 28.37 | 41.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.85 | 22.26 | 21.69 | 25.5 | 37.95 | |||||
Dividend Per Share, 5 Yr. CAGR % | -14.76 | -6.23 | 0 | 26.45 | - |
- Stock Market
- Stocks
- MTO Stock
- Financials Mitie Group plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















